A mouse herpesvirus induces relapse of experimental autoimmune arthritis by infection of the inflammatory target tissue

Journal of Immunology

Volumn 173, Issue 8, 2004, Pages 5238-5246

  Yarilin, Dmitry A ^a   Valiando, Jennifer ^a   Posnett, David N ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; CYCLOPHOSPHAMIDE; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRON MICROSCOPY; HERPES VIRUS; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELAPSE; SYNOVIUM; TARGET ORGAN; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 6344250541     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.8.5238     Document Type: Article

References (62)

1. Wucherpfennig, K. W. 2001. Mechanisms for the induction of autoimmunity by infectious agents. J. Clin. Invest. 108:1097.
2. Hafler, D. A. 1999. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis. J. Clin. Invest. 104:527.
3. Benoist, C., and D. Mathis. 2001. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2:797.
4. Miller, S. D., C. L. Vanderlugt, W. S. Begolka, W. Pao, R. L. Yauch, K. L. Neville, Y. Katz-Levy, A. Carrizosa, and B. S. Kim. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:1133.
5. Wolfe, F., K. Ross, D. J. Hawley, F. K. Roberts, and M. A. Cathey. 1993. The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients. J. Rheumatol. 20:2005.
6. Bodolay, E., Z. Csiki, Z. Szekanecz, T. Ben, E. Kiss, M. Zeher, G. Szucs, K. Danko, and G. Szegedi. 2003. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin. Exp. Rheumatol. 21:313.
7. Harrison, B. J., D. P. Symmons, P. Brennan, E. M. Barrett, and A. J. Silman. 1996. Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br. J. Rheumatol. 35:1096.
8. Francis, D. A., D. A. Compston, J. R. Batchelor, and W. I. McDonald. 1987. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J. Neurol. Neurosurg. Psychiatry 50:758.
9. Rizzo, J. F., and S. Lessell. 1988. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology 38:185.
10. Soderstrom, M., J. Ya-Ping, J. Hillert, and H. Link. 1998. Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology 50:708.
11. Ray, C. G., E. P. Gall, L. L. Minnich, J. Roediger, C. De Benedetti, and J. J. Corrigan. 1982. Acute polyarthritis associated with active Epstein-Barr virus infection. JAMA 248:2990.
12. Jokinen, E. I., T. T. Mottonen, P. J. Hannonen, M. Makela, and H. S. Arvilommi. 1994. Prediction of severe rheumatoid arthritis using Epstein-Barr virus. Br. J. Rheumatol. 33:917.
13. Blaschke, S., G. Schwarz, D. Moneke, L. Binder, G. Muller, and M. Reuss-Borst. 2000. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis. J. Rheumatol. 27:866.
14. Posnett, D. N., and J. Edinger. 1997. When do microbes stimulate rheumatoid factor? J. Exp. Med. 185:1721.
15. Vaughan, J. H. 1995. The Epstein-Barr virus in autoimmunity. Springer Semin. Immunopathol. 17:203.
16. Saal, J. G., M. Krimmel, M. Steidle, F. Gerneth, S. Wagner, P. Fritz, S. Koch, J. Zacher, S. Sell, H. Einsele, and C. A. Muller. 1999. Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. Arthritis Rheum. 42:1485.
17. Scotet, E., J. David-Ameline, M.-A. Peyrat, A. Moreau-Aubry, D. Pinczon, A. Lim, J. Even, G. Semana, J.-M. Berthelot, R. Reathnach, et al. 1996. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J. Exp. Med. 184:1791.
18. Scotet, E., M. A. Peyrat, X. Saulquin, C. Retiere, C. Couedel, F. Davodeau, N. Dulphy, A. Toubert, J. D. Bignon, A. Lim, et al. 1999. Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: toward a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur. J. Immunol. 29:973.
19. Edinger, J. W., and D. N. Posnett. 1999. T cell antigen receptor repertoire in rheumatoid arthritis. In Pathogenic Autoimmune Reactions. S. Paul, ed. Humana, Totowa, NJ, p. 113.
20. Edinger, J. W., M. Bonneville, E. Scotet, E. Houssaint, H. R. Schumacher, and D. N. Posnett. 1998. EBV gene expression not altered in rheumatoid synovia despite the presence of EBV antigen-specific T cell clones. J. Immunol. 162:3694.
21. + T cells found within the joints of patients with inflammatory arthritis. Arthritis Rheum. 44:2038.
22. + T cells that are specific for certain viral epitopes. Arthritis Res. 2:154.
23. Koide, J., K. Takada, M. Sugiura, H. Sekine, T. Ito, K. Saito, S. Mori, T. Takeuchi, S. Uchida, and T. Abe. 1997. Spontaneous establishment of an Epstein-Barr virus infected fibroblast line from the synovial tissue of a rheumatoid arthritis patient. J. Virol. 71:2478.
24. Takeda, T., Y. Mizugaki, L. Matsubara, S. Imai, T. Koike, and K. Takada. 2000. Lytic Epstein-Barr virus infection in the synovial tissue of patients witn rheumatoid arthritis. Arthritis Rheum. 43:1218.
25. Kouskoff, V., A. S. Korganow, V. Duchatelle, C. Degott, C. Benoist, and D. Mathis. 1996. Organ-specific disease provoked by systemic autoimmunity. Cell 87:811.
26. Korganow, A. S., H. Ji, S. Mangialaio, V. Duchatelle, R. Pelanda, T. Martin, C. Degott, H. Kikutani, K. Rajewsky, J. L. Pasquali, C. Benoist, and D. Mathis. 1999. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10:451.
27. Matsumoto, I., A. Staub, C. Benoist, and D. Mathis. 1999. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286:1732.
28. Wipke, B. T., Z. Wang, J. Kim, T. J. McCarthy, and P. M. Allen. 2002. Dynamic visualization of a joint-specific autoimmune response through positron emission tomography. Nat. Immunol. 3:366.
29. Matsumoto, I., M. Maccioni, D. M. Lee, M. Maurice, B. Simmons, M. Brenner, D. Mathis, and C. Benoist. 2002. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat. Immunol. 3:360.
30. Ji, H., K. Ohmura, U. Mahmood, D. M. Lee, F. M. Hofhuis, S. A. Boackle, K. Takahashi, V. M. Holers, M. Walport, C. Gerard, et al. 2002. Arthritis critically dependent on innate immune system players. Immunity 16:p157.
31. Matsumoto, I., D. M. Lee, R. Goldbach-Mansky, T. Sumida, C. A. Hitchon, P. H. Schur, R. J. Anderson, J. S. Coblyn, M. E. Weinblatt, M. Brenner, et al. 2003. Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis Rheum. 48:944.
32. Weck, K. E., S. S. Kim, H. W. I. V. Virgin, and S. H. Speck. 1999. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J. Virol. 73:3273.
33. Week, K. E., S. S. Kim, H. W. I. V. Virgin, and S. H. Speck. 1999. B cells regulate murine gammaherpesvirus 68 latency. J. Virol. 73:4651.
34. Stewart, J. P., E. J. Usherwood, A. Ross, H. Dyson, and T. Nash. 1998. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J. Exp. Med. 187:1941.
35. + T cells. J. Exp. Med. 184:863.
36. Neyts, J., and E. De Clercq. 1998. In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents. Antimicrob. Agents Chemother. 42:170.
37. + T cell response during acute and persistent murine gamma-herpesvirus infection. Eur. J. Immunol. 29:1059.
38. Sunil-Chandra, N. P., J. Arno, J. Fazakerley, and A. A. Nash. 1994. Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Am. J. Pathol. 145:818.
39. Weck, K. E., A. J. Dal Canto, J. D. Gould, A. K. O'Guin, K. A. Roth, J. E. Saffitz, S. H. Speck, and H. W. Virgin. 1997. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-γ responsiveness: a new model for virus-induced vascular disease. Nat. Med. 3:1346.
40. Sunil-Chandra, N. P., S. Efstathiou, J. Arno, and A. A. Nash. 1992. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J. Gen. Virol. 73:2347.
41. Gangappa, S., L. F. van Dyk, T. J. Jewett, S. H. Speck, and H. W. Virgin. 2002. Identification of the in vivo role of a viral bcl-2. J. Exp. Med. 195:931.
42. Dal Canto, A. J., H. W. Virgin, and S. H. Speck. 2000. Ongoing vital replication is required for gammaherpesvirus 68-induced vascular damage. J. Virol. 74:11304.
43. Tripp, R. A., A. M. Hamilton-Easton, R. D. Cardin, P. Nguyen, F. G. Behm, D. L. Woodland, P. C. Doherty, and M. A. Blackman. 1997. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J. Exp. Med. 185:1641.
44. + T-cell lymphocytosis associated with murine gamma-herpesvirus infection. Viral Immunol. 14:391.
45. Bologna, C., P. Viu, M. C. Picot, C. Jorgensen, and J. Sany. 1997. Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: an open, retrospective, observational study. Br. J. Rheumatol. 36:535.
46. Mielants, H., E. M. Veys, C. Van der Straeten, C. Ackerman, and S. Goemaere. 1991. The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis: an open prospective study. J. Rheumatol. 18:978.
47. James, J. A., K. M. Kaufman, A. D. Farris, E. Taylor-Albert, T. J. Lehman, and J. B. Harley. 1997. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Invest. 100:3019.
48. Simmons, A. 2001. Herpesvirus and multiple sclerosis. Herpes 8:60.
49. Berti, R., S. S. Soldan, N. Akhyani, H. F. McFarland, and S. Jacobson. 2000. Extended observations on the association of HHV-6 and multiple sclerosis. J. Neurovirol. 6(Suppl. 2):S85.
50. Peacock, J. W., S. F. Elsawa, C. C. Petty, W. F. Hickey, and K. L. Bost. 2003. Exacerbation of experimental autoimmune encephalomyelitis in rodents infected with murine gammaherpesvirus-68. Eur. J. Immunol. 33:1849.
51. Du, C., S. Y. Yao, A. Ljunggren-Rose, and S. Sriram. 2003. Chlamydia pneumoniae infection of the central nervous system worsens experimental allergic encephalitis. J. Exp. Med. 196:1639.
52. Gerard, H. C. 4, Z. Wang, G. F. Wang, H. El-Gabalawy, R. Goldbach-Mansky, Y. Li, W. Majeed, H. Zhang, N. Ngai, A. P. Hudson, and H. R. Schumacher. 2001. Chromosomal DNA from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis. Arthritis Rheum. 44:1689.
53. Kamel, O. W. 1997. Iatrogenic lymphoproliferative disorders in nontransplantation settings. Semin. Diagn. Pathol. 14:27.
54. Mariette, X., D. Cazals-Hatem, J. Warszawki, F. Liote, N. Balandraud, and J. Sibilia. 2002. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 99:3909.
55. Horwitz, M. S., L. M. Bradley, J. Harbertson, T. Krahl, J. Lee, and N. Sarvetnick. 1998. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4:781.
56. Rodriguez-Garcia, M. I., J. A. Fernandez, A. Rodriguez, M. P. Fernandez, C. Gutierrez, and J. C. Torre-Alonso. 1996. Annexin V autoantibodies in rheumatoid arthritis. Ann. Rheum. Dis. 55:895.
57. Lettesjo, H., E. Nordstrom, H. Strom, and E. Moller. 1998. Autoantibody patterns in synovial fluids from patients with rheumatoid arthritis or other arthritic lesions. Scand. J. Immunol. 48:293.
58. Goldbach-Mansky, R., J. Lee, A. McCoy, J. Hoxworth, C. Yarboro, J. S. Smolen, G. Steiner, A. Rosen, C. Zhang, H. A. Menard, et al. 2000. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res. 2:236.
59. Van Venrooij, W. J., and G. J. Pruijn. 2003. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res. 2:249.
60. Shrivastav, M., B. Mittal, A. Aggarwal, and R. Misra. 2002. Autoantibodies against cytoskeletal proteins in rheumatoid arthritis. Clin. Rheumatol. 21:505.
61. Smolen, J. S., W. Hassfeld, W. Graninger, and G. Steiner. 1990. Antibodies to antinuclear subsets in systemic lupus erythematosus and rheumatoid arthritis. Clin. Exp. Rheumatol. 8(Suppl. 5):41.
62. Menard, H. A., E. Lapointe, M. D. Rochdi, and Z. J. Zhou. 2000. Insights into rheumatoid arthritis derived from the Sa immune system. Arthritis Res. 2:429.